Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.
This non-discretionary sale tied to restricted stock unit vesting reduced the CFO's direct holdings by 3%, though he retains a $12.1 million equity stake in the healthcare platform operator.
Matthew Sonefeldt, Doximity's CFO, filed a Form 4 report on August 15, selling 15,311 shares of Class A Common Stock. This tax-related disposition does not reflect a shift in his outlook on the firm. Sonefeldt still holds a significant 486,238 shares, valued at $12.1 million at the market close price of $24.80 on August 14. Doximity is a digital health platform for healthcare practitioners, generating $655.6 million in trailing 12-month revenue and $167.0 million in net income.
Revenue rose 7% to $156.6 million, but guided growth for the September quarter is expected to be around 1%. AI compute costs and stock buybacks impacted gross margin and adjusted EBITDA. Despite internal concerns, Doximity's competitive advantage lies in its comprehensive practitioner network, integrated tools, and established relationships with customers.
Written by urgent.news from Yahoo Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
